emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
- RxCUI
- 476556
- RxNorm name
- emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
- Display name
- emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
- Full name
- emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:59
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Major Pharmaceuticals | a78b51c9-c944-4b00-af81-9ecbfbb29fd1 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | NuCare Pharmaceuticals, Inc. | 4feb83a5-9142-0c67-e063-6394a90a710f | 2026-04-20 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Bryant Ranch Prepack | b8c5f114-61db-4797-b75e-c103d2d1820e | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and tenofovir disoproxil fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Proficient Rx LP | 1289b02c-50f7-4adc-80d1-24afc1bad01b | 2026-02-01 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Strides Pharma Science Limited | bc37cba9-83c8-4660-a527-cd77fae9ea87 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and tenofovir disoproxil fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Redpharm Drug | 44f2503d-7863-61a8-e063-6394a90a83c4 | 2025-12-13 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and tenofovir disoproxil fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | A-S Medication Solutions | 4d1fd81c-8bb5-4b04-a284-b35f74a955a0 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Laurus Labs Limited | 4a7ccbbf-da20-4012-9717-31c411efb3fb | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Truvada | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Gilead Sciences, Inc | 54e82b13-a037-49ed-b4b3-030b37c0ecdd | 2025-07-16 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | AvKARE | 38e06005-b998-9abb-e063-6294a90a71cb | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and tenofovir disoproxil fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | NuCare Pharmaceuticals, Inc. | 33149d27-687e-a092-e063-6294a90ab39b | 2025-04-18 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and tenofovir disoproxil fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Camber Pharmaceuticals, Inc. | 7fa6961e-3602-4e31-a60a-e5735899f63b | 2025-04-14 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine/TDF | EMTRICITABINE/TDF | Direct_Rx | ef1a90ca-92bc-3787-e053-2a95a90a58ec | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 476556 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | DirectRx | d67e2df4-4094-4f5a-e053-2a95a90ae4aa | 2025-01-21 | Warnings, Adverse reactions | 476556 |
| Emtricitabine and tenofovir disoproxil fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | NuCare Pharmaceuticals, Inc. | 23ae0a72-adcf-fdd0-e063-6394a90abe63 | 2024-12-26 | Boxed warning, Warnings, Adverse reactions | 476556 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Cipla USA Inc. | d08c9455-e788-435c-9076-2bdb1a4f5b37 | 2024-12-05 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and tenofovir disoproxil fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Zydus Lifesciences Limited | a0ee89b6-72c3-4b99-8d1c-d7473f1d5ef3 | 2024-11-28 | 476556 | |
| Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Proficient Rx LP | d3b849a7-219d-4acc-9e29-8f246cb4a7a9 | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Teva Pharmaceuticals USA, Inc. | e1e4d828-7870-4ea9-a66a-e658487bd859 | 2024-09-30 | Boxed warning, Warnings, Adverse reactions | 476556 |
| Truvada | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | NuCare Pharmaceuticals,Inc. | 46e06df0-654d-43cc-e054-00144ff8d46c | 2024-07-16 | Boxed warning, Warnings, Adverse reactions | 476556 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 54e82b13-a037-49ed-b4b3-030b37c0ecdd | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 32 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | 20250716 |
| 54e82b13-a037-49ed-b4b3-030b37c0ecdd | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 32 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | 20250716 |
| 54e82b13-a037-49ed-b4b3-030b37c0ecdd | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 32 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | 20250716 |
| e1e4d828-7870-4ea9-a66a-e658487bd859 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240930 |
| e1e4d828-7870-4ea9-a66a-e658487bd859 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 15 | These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240930 |
| e1e4d828-7870-4ea9-a66a-e658487bd859 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 15 | These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240930 |
| 8bd3debe-d414-450f-b8d9-a70fb1dd5341 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 12 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA™ (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2004 | 20250716 |
| 8bd3debe-d414-450f-b8d9-a70fb1dd5341 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 12 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA™ (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2004 | 20250716 |
| 8bd3debe-d414-450f-b8d9-a70fb1dd5341 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 12 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA™ (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2004 | 20250716 |
| 00b4b5b5-7220-410c-8db2-dd940498cfc2 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 12 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | 20210615 |
| 00b4b5b5-7220-410c-8db2-dd940498cfc2 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 12 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | 20210615 |
| 00b4b5b5-7220-410c-8db2-dd940498cfc2 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 12 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | 20210615 |
| e4fb5710-e23b-429e-9b51-c12366e614fc | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 11 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | 20231102 |
| e4fb5710-e23b-429e-9b51-c12366e614fc | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | 20231102 |
| e4fb5710-e23b-429e-9b51-c12366e614fc | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 11 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | 20231102 |
| 94d78028-4ba5-4a5d-bd6f-5eca2a1b4b9d | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20210828 |
| 94d78028-4ba5-4a5d-bd6f-5eca2a1b4b9d | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 11 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20210828 |
| 94d78028-4ba5-4a5d-bd6f-5eca2a1b4b9d | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 11 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20210828 |
| bc37cba9-83c8-4660-a527-cd77fae9ea87 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 10 | These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20260108 |
| bc37cba9-83c8-4660-a527-cd77fae9ea87 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 10 | These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20260108 |
| bc37cba9-83c8-4660-a527-cd77fae9ea87 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 10 | These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20260108 |
| b0459301-2bff-4336-9172-b90c7a582433 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 9 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20201129 |
| b0459301-2bff-4336-9172-b90c7a582433 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 9 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20201129 |
| b0459301-2bff-4336-9172-b90c7a582433 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 9 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20201129 |
| 4a7ccbbf-da20-4012-9717-31c411efb3fb | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 8 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20250820 |
| 4a7ccbbf-da20-4012-9717-31c411efb3fb | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20250820 |
| 4a7ccbbf-da20-4012-9717-31c411efb3fb | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 8 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20250820 |
| 7def7a95-e69e-4985-974a-efacadcecc95 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240510 |
| 7def7a95-e69e-4985-974a-efacadcecc95 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 8 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240510 |
| 7def7a95-e69e-4985-974a-efacadcecc95 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 8 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240510 |
| bdd87563-251a-d990-e053-2a95a90ad578 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 7 | EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | 20240408 |
| bdd87563-251a-d990-e053-2a95a90ad578 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 7 | EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | 20240408 |
| bdd87563-251a-d990-e053-2a95a90ad578 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 7 | EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | 20240408 |
| a78b51c9-c944-4b00-af81-9ecbfbb29fd1 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 6 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20251224 |
| a78b51c9-c944-4b00-af81-9ecbfbb29fd1 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 6 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20251224 |
| a78b51c9-c944-4b00-af81-9ecbfbb29fd1 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 6 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20251224 |
| a0ee89b6-72c3-4b99-8d1c-d7473f1d5ef3 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 6 | Emtricitabine and Tenofovir Disoproxil Fumarate Tablets | 20241128 |
| a0ee89b6-72c3-4b99-8d1c-d7473f1d5ef3 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 6 | Emtricitabine and Tenofovir Disoproxil Fumarate Tablets | 20241128 |
| a0ee89b6-72c3-4b99-8d1c-d7473f1d5ef3 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 6 | Emtricitabine and Tenofovir Disoproxil Fumarate Tablets | 20241128 |
| c0aa7cb1-ae20-2cbc-e053-2995a90a3284 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 6 | EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets | 20240807 |
| c0aa7cb1-ae20-2cbc-e053-2995a90a3284 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 6 | EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets | 20240807 |
| c0aa7cb1-ae20-2cbc-e053-2995a90a3284 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 6 | EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets | 20240807 |
| d8c32565-9ff2-4bfb-a5cf-ae6e0e498ccc | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 6 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240609 |
| d8c32565-9ff2-4bfb-a5cf-ae6e0e498ccc | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 6 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240609 |
| d8c32565-9ff2-4bfb-a5cf-ae6e0e498ccc | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 6 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240609 |
| 46e06df0-654d-43cc-e054-00144ff8d46c | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 5 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | 20240716 |
| 46e06df0-654d-43cc-e054-00144ff8d46c | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 5 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | 20240716 |
| 46e06df0-654d-43cc-e054-00144ff8d46c | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 5 | These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | 20240716 |
| bc858a35-e0e1-450b-95c3-db3a4fe51a4c | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 5 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20230525 |
| bc858a35-e0e1-450b-95c3-db3a4fe51a4c | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 5 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20230525 |
| bc858a35-e0e1-450b-95c3-db3a4fe51a4c | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 5 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20230525 |
| ef1a90ca-92bc-3787-e053-2a95a90a58ec | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 4 | Emtricitabine/TDF | 20250122 |
| ef1a90ca-92bc-3787-e053-2a95a90a58ec | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 4 | Emtricitabine/TDF | 20250122 |
| ef1a90ca-92bc-3787-e053-2a95a90a58ec | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 4 | Emtricitabine/TDF | 20250122 |
| d08c9455-e788-435c-9076-2bdb1a4f5b37 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 4 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20241205 |
| d08c9455-e788-435c-9076-2bdb1a4f5b37 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 4 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20241205 |
| d08c9455-e788-435c-9076-2bdb1a4f5b37 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20241205 |
| 4f4268c2-42aa-49fa-e054-00144ff88e88 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 4 | 20240715 | |
| 4f4268c2-42aa-49fa-e054-00144ff88e88 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 4 | 20240715 | |
| 4f4268c2-42aa-49fa-e054-00144ff88e88 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 4 | 20240715 | |
| 7bf86d9d-999a-4b64-849a-0d43bbf7b766 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 4 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240516 |
| 7bf86d9d-999a-4b64-849a-0d43bbf7b766 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 4 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240516 |
| 7bf86d9d-999a-4b64-849a-0d43bbf7b766 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240516 |
| 7fa6961e-3602-4e31-a60a-e5735899f63b | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20250414 |
| 7fa6961e-3602-4e31-a60a-e5735899f63b | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20250414 |
| 7fa6961e-3602-4e31-a60a-e5735899f63b | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 3 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20250414 |
| 4af2529d-a14f-4337-87ed-04f8f27da746 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 3 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240609 |
| 4af2529d-a14f-4337-87ed-04f8f27da746 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240609 |
| 4af2529d-a14f-4337-87ed-04f8f27da746 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20240609 |
| 7ecc604c-c4b4-4419-a733-ecb11662fc81 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | 20240318 |
| 7ecc604c-c4b4-4419-a733-ecb11662fc81 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 3 | These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | 20240318 |
| 7ecc604c-c4b4-4419-a733-ecb11662fc81 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | 20240318 |
| 70b3deb4-951d-4d9b-a811-be5fa05529a9 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 3 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20200720 |
| 70b3deb4-951d-4d9b-a811-be5fa05529a9 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20200720 |
| 70b3deb4-951d-4d9b-a811-be5fa05529a9 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20200720 |
| b8c5f114-61db-4797-b75e-c103d2d1820e | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20260310 |
| b8c5f114-61db-4797-b75e-c103d2d1820e | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20260310 |
| b8c5f114-61db-4797-b75e-c103d2d1820e | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 2 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20260310 |
| 44f2503d-7863-61a8-e063-6394a90a83c4 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20251213 |
| 44f2503d-7863-61a8-e063-6394a90a83c4 | emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet | SY | 2 | These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | 20251213 |